+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 0 - 25Years
All Genders
ID07621614

Central Pathology and Molecular Risk-Based Surgical Management Study for Pediatric Melanoma and Related Skin Tumors

Led by Children's Oncology Group · Updated on 2026-09-24

51

Participants Needed

13

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to compare a risk-based stratification approach to usual surgical methods in treating children and young adults with localized cutaneous melanoma, atypical SpitzSpitzoid tumors, or other atypical melanocytic tumors. These skin tumors can be challenging to diagnose accurately in younger patients, and misclassification can lead to either insufficient surgery or unnecessary treatment. The study evaluates the use of tumor pathology and genetic markers to classify tumors by risk level to guide surgical decisions more safely and effectively. Participants are divided into three groups based on tumor classification those with non-atypical tumors are observed without surgery those with low-risk atypical tumors undergo a narrow margin re-excision without sentinel lymph node biopsy and those with high-risk atypical tumors receive wide local excision with or without sentinel lymph node biopsy following adult melanoma guidelines. Additional procedures such as blood sample collection, chest x-rays, CT scans, MRI, PETCT or PETMRI, nodal basin ultrasound, and brain MRI may be performed in the high-risk group. Follow-up schedules vary depending on the group, ranging from every six months to annually for up to five years. Throughout the study, participants undergo clinical assessments, imaging scans, and blood tests as appropriate to their assigned group. Researchers monitor adherence to the assigned surgical procedures, surgical complications, progression-free survival, and overall survival. The study also examines surgical reconstruction techniques, pathology concordance, and molecular biomarkers related to tumor behavior. Participants are followed closely for up to five years to evaluate outcomes and safety, with primary feasibility assessed within eight weeks of enrollment.

CONDITIONS

Brief Title

A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here